{
    "clinical_study": {
        "@rank": "48469", 
        "arm_group": {
            "arm_group_label": "imipramine", 
            "arm_group_type": "Active Comparator"
        }, 
        "brief_summary": {
            "textblock": "Esophageal hypersensitivity/Functional heartburn are common among non-erosive reflux disease\n      (NERD) patients who do not response to proton pump inhibitors. Whether tricyclic\n      antidepressant improves NERD patient's symptoms remains unknown\n\n      Aim of  this randomized controlled trial study is  to determine the efficacy of  imipramine,\n      which could increase esophageal pain thresholds in healthy volunteers, in comparison with\n      placebo for treatment patients with esophageal hypersensitivity or functional heartburn\n      evaluated by improvement of specific-symptom score and quality of life"
        }, 
        "brief_title": "Efficacy of Imipramine for Treatment of Patients With Esophageal Hypersensitivity/ Functional Heartburn", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Gastroesophageal Reflux Disease", 
        "condition_browse": {
            "mesh_term": [
                "Gastroesophageal Reflux", 
                "Hypersensitivity"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patient with typical reflux symptoms (heartburn and/or regurgitation) more than 3\n             times per week in at least last 3 months\n\n          -  Age more than 18 years\n\n          -  Upper GI endoscopy showed no esophageal mucosal breaks\n\n          -  MII-pH monitoring was not showed abnormal both acid and non-acid reflux\n\n          -  symptoms was not improved after received  standard dose proton pump inhibitor for at\n             least 1 month\n\n        Exclusion Criteria:\n\n          -  history of thoracic, esophagus, or stomach surgery\n\n          -  severe esophageal motility disorder eg. Achalasia, scleroderma, autonomic/peripheral\n             neuropathy/myopathy\n\n          -  patient who was indicated to receive proton pump inhibitor\n\n          -  pregnant women\n\n          -  patient who was allergy to imipramine\n\n          -  patient who received tricyclic antidepressant or SSRI with in 3 month of enrollment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01753128", 
            "org_study_id": "334/2553 (EC3)"
        }, 
        "intervention": {
            "arm_group_label": "imipramine", 
            "intervention_name": "imipramine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Imipramine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 19, 2012", 
        "location": {
            "contact": {
                "email": "alimsrivilai@gmail.com", 
                "last_name": "Julajak Limsrivilai, MD", 
                "phone": "66814968895"
            }, 
            "facility": {
                "address": {
                    "city": "Bangkok", 
                    "country": "Thailand", 
                    "zip": "10700"
                }, 
                "name": "Medical Institue; Siriraj Hospital"
            }, 
            "investigator": {
                "last_name": "Julajak Limsrivilai, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "1", 
        "official_title": "Efficacy of Imipramine for Treatment of Patients With Esophageal", 
        "overall_contact": {
            "email": "alimsrivilai@gmail.com", 
            "last_name": "Julajak Limsrivilai, MD", 
            "phone": "66814968895"
        }, 
        "overall_official": {
            "affiliation": "Mahidol University", 
            "last_name": "Julajak Limsrivilai, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "improvement of GERD score", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01753128"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "improve quality of life", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "source": "Mahidol University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mahidol University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2010"
    }
}